CAS No. |
50932-19-9 |
中文名称 |
(1aS,1bS,2S,5aR,6S,6aS)-1a-(羟甲基)-2-[[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基]氧基]-1a,1b,2,5a,6,6a-六氢环氧烯并[2',3':4,5]环戊并[1,2-c]吡喃-6-基(E)-3-(3,4-二羟基苯基)丙烯酸酯 |
英文名称 |
(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1a,1b,2,5a,6,6a-hexahydrooxireno[2',3':4,5]cyclopenta[1,2-c]pyran-6-yl (E)-3-(3,4-dihydroxyphenyl)acrylate |
别名 |
[(1aS)-6α-[[(E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1a,1bα,2,5aα,6,6aβ-hexahydro-1a-hydroxymethyloxireno[4,5]cyclopenta[1,2-c]pyran-2α-yl]β-D-glucopyranoside;Verminoside;Vermiside;Caffeoyl catalpol;Catalpol 6-caffeate;β-D-Glucopyranoside, (1aS,1bS,2S,5aR,6S,6aS)-6-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1a,1b,2,5a,6,6a-hexahydro-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl;(1aS)-6α-[[(E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1a,1bα,2,5aα,6,6aβ-hexahydro-1a-hydroxymethyloxireno[4,5]cyclopenta[1,2-c]pyran-2α-yl]β-D-glucopyranoside |
标准英文名 |
(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1a,1b,2,5a,6,6a-hexahydrooxireno[2',3':4,5]cyclopenta[1,2-c]pyran-6-yl (E)-3-(3,4-dihydroxyphenyl)acrylate |
分子式 |
C24H28O13 |
分子量 |
524.47
|
精确分子量 |
524.15
|
SMILES |
O=C(/C=C/C1=CC(O)=C(O)C=C1)O[C@H]1[C@@H]2C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2[C@@]2(CO)O[C@@H]12 |
标准SMILES |
OC1C=CC(/C=C/C(=O)O[C@@H]2[C@@H]3O[C@]3(CO)[C@H]3[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)OC=C[C@@H]23)=CC=1O |
用途 |
Verminoside exhibits anti-inflammatory and significant antioxidant activities, with a radical scavenging activity of 2.5 μg/mL; it shows concentration-dependent inhibition of iNOS expression in LPS-stimulated J774.A1 macrophages at concentrations of 0.1 mM and 1 mM; it is associated with genotoxicity in human lymphocytes through upregulation of PARP-1 and p53 protein levels. |
InChIKey |
MZQXNUBTVLKMLP-QOEJBJAYSA-N |